Literature DB >> 23104121

Solution structure of subunit γ (γ(1-204)) of the Mycobacterium tuberculosis F-ATP synthase and the unique loop of γ(165-178), representing a novel TB drug target.

Ragunathan Priya1, Goran Biuković, Malathy Sony Subramanian Manimekalai, Jackwee Lim, Srinivasa P S Rao, Gerhard Grüber.   

Abstract

Tuberculosis, caused by the strain Mycobacterium tuberculosis, is in focus of interest due to the emergence of multi- and extensive drug-resistant TB strains. The F(1)F(O) ATP synthase is one of the essential enzymes in energy requirement of both proliferating aerobic and hypoxic dormant stage of mycobacterium life cycle, and therefore a potential TB drug target. Subunit γ of F-ATP synthases plays an important role in coupling and catalysis via conformational transitions of its N- and C-termini as well as the bottom segment of the globular domain of γ, which is in close proximity to the rotating and ion-pumping c-ring. Here we describe the first production, purification and low resolution solution structure of subunit γ (γ(1-204), Mtγ(1-204)) of the M. tuberculosis F-ATP synthase. Mtγ(1-204) is a pear-like shaped protein with a molecular weight of 23 ± 2 kDa. Protein sequence analysis of Mtγ revealed differences in the amino acid composition to γ subunits from other sources, in particular the presence of a unique stretch of 13 amino acid residues (Mtγ(165-178)). NMR studies showed that Mtγ(165-178) forms a loop of polar residues. Mtγ(165-178) has been aligned at the bottom of the globular domain of the Escherichia coli subunit γ, being in close vicinity to the polar residues R41, Q42, E44 and Q46 (M. tuberculosis nomenclature) of the c-ring. The putative role(s) of Mtγ(165-178) in coupling and as a potential drug target are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23104121     DOI: 10.1007/s10863-012-9486-4

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  22 in total

1.  Dormant tubercle bacilli: the key to more effective TB chemotherapy?

Authors:  T Dick
Journal:  J Antimicrob Chemother       Date:  2001-01       Impact factor: 5.790

2.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

3.  The structure of the central stalk in bovine F(1)-ATPase at 2.4 A resolution.

Authors:  C Gibbons; M G Montgomery; A G Leslie; J E Walker
Journal:  Nat Struct Biol       Date:  2000-11

4.  Determination of domain structure of proteins from X-ray solution scattering.

Authors:  D I Svergun; M V Petoukhov; M H Koch
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

5.  Expression, purification, and characterization of subunit E, an essential subunit of the vacuolar ATPase.

Authors:  Gerhard Grüber; Jasminka Godovac-Zimmermann; Thomas A Link; Unal Coskun; Vincenzo F Rizzo; Christian Betz; Susanne M Bailer
Journal:  Biochem Biophys Res Commun       Date:  2002-11-01       Impact factor: 3.575

6.  Automated NMR structure calculation with CYANA.

Authors:  Peter Güntert
Journal:  Methods Mol Biol       Date:  2004

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  An interactive graphic program for calculating the secondary structure content of proteins from circular dichroism spectrum.

Authors:  G Deléage; C Geourjon
Journal:  Comput Appl Biosci       Date:  1993-04

Review 9.  Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development.

Authors:  Liem Nguyen; Jean Pieters
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

Review 10.  The past and future of tuberculosis research.

Authors:  Iñaki Comas; Sebastien Gagneux
Journal:  PLoS Pathog       Date:  2009-10-26       Impact factor: 6.823

View more
  4 in total

Review 1.  Energy metabolism and drug efflux in Mycobacterium tuberculosis.

Authors:  Philippa A Black; Robin M Warren; Gail E Louw; Paul D van Helden; Thomas C Victor; Bavesh D Kana
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

2.  The uniqueness of subunit α of mycobacterial F-ATP synthases: An evolutionary variant for niche adaptation.

Authors:  Priya Ragunathan; Hendrik Sielaff; Lavanya Sundararaman; Goran Biuković; Malathy Sony Subramanian Manimekalai; Dhirendra Singh; Subhashri Kundu; Thorsten Wohland; Wayne Frasch; Thomas Dick; Gerhard Grüber
Journal:  J Biol Chem       Date:  2017-05-11       Impact factor: 5.157

3.  The structure of the catalytic domain of the ATP synthase from Mycobacterium smegmatis is a target for developing antitubercular drugs.

Authors:  Alice Tianbu Zhang; Martin G Montgomery; Andrew G W Leslie; Gregory M Cook; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-25       Impact factor: 11.205

Review 4.  Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery.

Authors:  Iram Khan Iqbal; Sapna Bajeli; Ajit Kumar Akela; Ashwani Kumar
Journal:  Pathogens       Date:  2018-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.